Enantone and condition aggravated Patient Reports February 10, 2010

Enantone Side Effects Report #5109036-9
Enantone side effect was reported by a Health Professional from FRANCE on Sept 11, 2006. Male patient, 80 years of age, was diagnosed with prostate cancer  and was treated with Enantone. After drug was administered, patient experienced the following side effects: asthenia, condition aggravated, confusional state, hypocalcaemia, hypokalaemia, prostate cancer . Enantone dosage: 11.25 MG (11.25 MG, 1 IN 3 M) INTRAMUSCULAR. During the same period patient was treated with CLASTOBAN, ANANDRON. Patient died.

Enantone Side Effects Report #4886161-9
Enantone side effect was reported by a Health Professional from FRANCE on Jan 12, 2006. Male patient, 71 years of age, was diagnosed with prostate cancer  and was treated with Enantone. After drug was administered, patient experienced the following side effects: condition aggravated, cytolytic hepatitis, hepatic cirrhosis, hepatic fibrosis. Enantone dosage: 11.25 MG (11.25 MG, 1IN 3 M). Patient was hospitalized. Patient recovered.

Enantone Side Effects Report #4556584-6
Enantone side effect was reported by a Consumer or non-health professional from on Jan 07, 2005. Female patient, 32 years of age, was diagnosed with endometriosis  and was treated with Enantone. After drug was administered, patient experienced the following side effects: asthenia, bedridden, condition aggravated, hypopituitarism, infection , oestradiol decreased. Enantone dosage: 3.75 MG (3.75 MG, 1 IN 1 M). Patient was hospitalized. Patient recovered.